1358 related articles for article (PubMed ID: 18191732)
21. Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease--a randomized, controlled, open-label, multicenter study.
Schröder O; Mickisch O; Seidler U; de Weerth A; Dignass AU; Herfarth H; Reinshagen M; Schreiber S; Junge U; Schrott M; Stein J
Am J Gastroenterol; 2005 Nov; 100(11):2503-9. PubMed ID: 16279906
[TBL] [Abstract][Full Text] [Related]
22. Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia.
Li H; Wang SX
Blood Purif; 2008; 26(2):151-6. PubMed ID: 18212498
[TBL] [Abstract][Full Text] [Related]
23. Effects of 5'-phosphodiesterase four-week long inhibition with sildenafil in patients with chronic heart failure: a double-blind, placebo-controlled clinical trial.
Behling A; Rohde LE; Colombo FC; Goldraich LA; Stein R; Clausell N
J Card Fail; 2008 Apr; 14(3):189-97. PubMed ID: 18381181
[TBL] [Abstract][Full Text] [Related]
24. Decreased treatment failure rates following duodenal release ferrous glycine sulfate in iron deficiency anemia associated with autoimmune gastritis and Helicobacter pylori gastritis.
Hershko C; Ianculovich M; Souroujon M
Acta Haematol; 2007; 118(1):19-26. PubMed ID: 17426393
[TBL] [Abstract][Full Text] [Related]
25. A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERINJECT) randomized controlled trial.
Kulnigg S; Stoinov S; Simanenkov V; Dudar LV; Karnafel W; Garcia LC; Sambuelli AM; D'Haens G; Gasche C
Am J Gastroenterol; 2008 May; 103(5):1182-92. PubMed ID: 18371137
[TBL] [Abstract][Full Text] [Related]
26. Treatment with iron of patients with heart failure with and without anemia.
Jelani QU; Attanasio P; Katz SD; Anker SD
Heart Fail Clin; 2010 Jul; 6(3):305-12. PubMed ID: 20630405
[TBL] [Abstract][Full Text] [Related]
27. Prevalence, prognostic importance and therapeutic implications of anemia in heart failure.
Mishra TK; Mishra SK; Mohanty NK; Rath PK
Indian Heart J; 2005; 57(6):670-4. PubMed ID: 16521636
[TBL] [Abstract][Full Text] [Related]
28. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S
Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669
[TBL] [Abstract][Full Text] [Related]
29. Waltz dancing in patients with chronic heart failure: new form of exercise training.
Belardinelli R; Lacalaprice F; Ventrella C; Volpe L; Faccenda E
Circ Heart Fail; 2008 Jul; 1(2):107-14. PubMed ID: 19808280
[TBL] [Abstract][Full Text] [Related]
30. Randomized double-blind trial of darbepoetin alfa in patients with symptomatic heart failure and anemia.
Ghali JK; Anand IS; Abraham WT; Fonarow GC; Greenberg B; Krum H; Massie BM; Wasserman SM; Trotman ML; Sun Y; Knusel B; Armstrong P;
Circulation; 2008 Jan; 117(4):526-35. PubMed ID: 18195176
[TBL] [Abstract][Full Text] [Related]
31. Enhanced external counterpulsation improves exercise tolerance in patients with chronic heart failure.
Feldman AM; Silver MA; Francis GS; Abbottsmith CW; Fleishman BL; Soran O; de Lame PA; Varricchione T;
J Am Coll Cardiol; 2006 Sep; 48(6):1198-205. PubMed ID: 16979005
[TBL] [Abstract][Full Text] [Related]
32. Impaired insulin sensitivity as an independent risk factor for mortality in patients with stable chronic heart failure.
Doehner W; Rauchhaus M; Ponikowski P; Godsland IF; von Haehling S; Okonko DO; Leyva F; Proudler AJ; Coats AJ; Anker SD
J Am Coll Cardiol; 2005 Sep; 46(6):1019-26. PubMed ID: 16168285
[TBL] [Abstract][Full Text] [Related]
33. Dobutamine effects on spontaneous variability of ventricular arrhythmias in patients with severe chronic heart failure: the Italian Multicenter Study.
Puddu PE; Papalia U; Schiariti M; Usta C;
Ital Heart J; 2004 Sep; 5(9):693-701. PubMed ID: 15568599
[TBL] [Abstract][Full Text] [Related]
34. Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in systolic heart failure with QRS prolongation: COMPANION trial sub-study.
De Marco T; Wolfel E; Feldman AM; Lowes B; Higginbotham MB; Ghali JK; Wagoner L; Kirlin PC; Kennett JD; Goel S; Saxon LA; Boehmer JP; Mann D; Galle E; Ecklund F; Yong P; Bristow MR
J Card Fail; 2008 Feb; 14(1):9-18. PubMed ID: 18226768
[TBL] [Abstract][Full Text] [Related]
35. Effect of Ferric Carboxymaltose on Exercise Capacity in Patients With Chronic Heart Failure and Iron Deficiency.
van Veldhuisen DJ; Ponikowski P; van der Meer P; Metra M; Böhm M; Doletsky A; Voors AA; Macdougall IC; Anker SD; Roubert B; Zakin L; Cohen-Solal A;
Circulation; 2017 Oct; 136(15):1374-1383. PubMed ID: 28701470
[TBL] [Abstract][Full Text] [Related]
36. Anemia in heart failure may warrant more aggressive listing for cardiac transplantation.
Geisberg C; Nading MA; Listerman J; Huang R; Goring J; Butler J
Transplant Proc; 2006 Jun; 38(5):1499-500. PubMed ID: 16797342
[TBL] [Abstract][Full Text] [Related]
37. Intravenous ferric carboxymaltose compared with oral iron in the treatment of postpartum anemia: a randomized controlled trial.
Van Wyck DB; Martens MG; Seid MH; Baker JB; Mangione A
Obstet Gynecol; 2007 Aug; 110(2 Pt 1):267-78. PubMed ID: 17666600
[TBL] [Abstract][Full Text] [Related]
38. Erythropoietin in heart failure.
Silverberg DS; Wexler D; Blum M; Iaina A; Sheps D; Keren G; Schwartz D
Semin Nephrol; 2005 Nov; 25(6):397-403. PubMed ID: 16298262
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics, safety and tolerability of intravenous ferric carboxymaltose: a dose-escalation study in volunteers with mild iron-deficiency anaemia.
Geisser P; Banké-Bochita J
Arzneimittelforschung; 2010; 60(6a):362-72. PubMed ID: 20648928
[TBL] [Abstract][Full Text] [Related]
40. Effects of an accelerated intravenous iron regimen in hospitalized patients with advanced heart failure and iron deficiency.
Reed BN; Blair EA; Thudium EM; Waters SB; Sueta CA; Jensen BC; Rodgers JE
Pharmacotherapy; 2015 Jan; 35(1):64-71. PubMed ID: 25556867
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
